Euflexxa 1% 20 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DX25F6VFZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,193
Award facts
- Contract value 100% obligated
- $3,192.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,192.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 mL syringes (2 mL quantity) on September 18, 2025, with completion scheduled for September 19, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The contract was competitively awarded with no set-aside designation, and performance will occur at the vendor's corporate office in Conshohocken, Pennsylvania. Euflexxa is a hyaluronate-based injectable used for osteoarthritis treatment, representing the type of specialized pharmaceutical product within AmerisourceBergen's extensive federal medical supply portfolio.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through the DLA Medical Supply Chain and serves military and veteran healthcare systems. The company's IDC vehicle enables flexible fulfillment of critical medical commodities including specialty medications, branded and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the operational efficiency of the IDV structure, allowing the Defense Logistics Agency to procure specific pharmaceutical items on an as-needed basis while maintaining a pre-established supplier relationship with an approved vendor capable of meeting federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DX25F6VFZ?
SPE2DX25F6VFZ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 18, 2025.
How much is contract SPE2DX25F6VFZ worth?
The government has obligated $3,193 on SPE2DX25F6VFZ.
Is contract SPE2DX25F6VFZ an order under another contract?
Yes. SPE2DX25F6VFZ is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6VFZ competed?
The extent of competition for SPE2DX25F6VFZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award